Join Growin Stock Community!
Beta
Back to ABBV.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
eps-chart

ABBV EPS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for ABBV's EPS in Q1'26 shows a value of 0.39 USD, reflecting a moderate decline from the previous quarter's 1.02 USD in Q4'25 and indicating ongoing quarterly volatility in earnings performance. Over the period from Q2'23 to Q1'26, ABBV's EPS has exhibited a volatile trend with no clear overall direction, starting at 1.14 USD and dipping to a low of -0.01 USD in Q4'24 before recovering somewhat to 1.02 USD in Q4'25. Year-over-year EPS growth has been predominantly negative, with sharp declines such as -66.9% in Q4'23 and -88.6% in Q3'25, though a notable exception occurred in Q4'25 with a 103% surge; this instability highlights potential challenges in maintaining consistent profitability amid external factors affecting the pharmaceutical sector.